60 Degrees Pharmaceuticals
Stock Forecast, Prediction & Price Target
60 Degrees Pharmaceuticals Financial Estimates
60 Degrees Pharmaceuticals Revenue Estimates
60 Degrees Pharmaceuticals EBITDA Estimates
60 Degrees Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $1.16M N/A | $223.20K -80.76% | $253.57K 13.60% | Avg: $2.8M Low: $2.53M High: $3.06M avg. 1004.21% | Avg: $4.26M Low: $3.86M High: $4.66M avg. 52.32% | ||
Net Income
% change YoY
| $-4.25M N/A | $-6.18M -45.39% | $-3.76M 39.08% | Avg: $-1.33M Low: $-1.49M High: $-1.17M avg. 64.51% | Avg: $-290.50K Low: $-325.59K High: $-255.41K avg. 78.26% | ||
EBITDA
% change YoY
| $-1.01M N/A | $-1.71M -68.98% | $-1.42M 16.81% | Avg: $-2.12M Low: $-2.31M High: $-1.92M avg. -48.72% | Avg: $-3.23M Low: $-3.53M High: $-2.93M avg. -52.32% | ||
EPS
% change YoY
| -$0.74 N/A | -$1.07 -44.59% | -$0.95 11.21% | Avg: -$0.23 Low: -$0.26 High: -$0.2 avg. 75.78% | Avg: -$0.05 Low: -$0.06 High: -$0.04 avg. 78.26% | ||
Operating Expenses
% change YoY
| $1.43M N/A | $1.54M 7.50% | $4.93M 220.09% | Avg: $16.93M Low: $15.36M High: $18.51M avg. 243.34% | Avg: $25.80M Low: $23.40M High: $28.19M avg. 52.32% | ||
FAQ
What is 60 Degrees Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 71.38% in 2025-2026.
We have gathered data from 1 analysts. Their low estimate is -1.49M, average is -1.33M and high is -1.17M.
What is 60 Degrees Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 528.26% in 2025-2026.
We have gathered data from 1 analysts. Their low revenue estimate is $2.53M, average is $2.8M and high is $3.06M.
What is 60 Degrees Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 77.02% in 2025-2026.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.26, average is -$0.23 and high is $-0.20.